Clinical Trial Update: Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial in healthy adults evaluated the safety and immunogenicity of a dengue virus vaccine. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Dengue virus vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 1 | Status: COMPLETED